1. Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells
   Khushwant S. Yadav et al, 2023, Pharmaceutical Development and Technology CrossRef
2. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents
   Jia-Nian Chen et al, 2016, European Journal of Medicinal Chemistry CrossRef
3. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer
   Snehal K. Shukla et al, 2020, Pharmaceutical Research CrossRef
4. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach
   Fereshteh Azimian et al, 2020, European Journal of Medicinal Chemistry CrossRef
5. Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo
   Huaimin Liu et al, 2014, Tumor Biology CrossRef
6. Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion
   Leticia Serrano-Oviedo et al, 2018, PLOS ONE CrossRef
7. E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
   Zhifeng Ma et al, 2023, Current Molecular Pharmacology CrossRef